WASHINGTON (Reuters) - U.S. health regulators are adding information to the labels on a popular class of birth control pills that includes Bayer AG's Yaz and Yasmin, to show they may raise the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results